The new immunosuppression.

New knowledge on how lymphocytes become tolerant to antigens is now enabling novel tolerance-harnessing strategies to enter the clinical arena. In the field of transplantation, monoclonal antibodies used either to deplete lymphocytes or to block T-cell function can induce tolerance in mice and non-h...

Full description

Bibliographic Details
Main Author: Waldmann, H
Format: Journal article
Language:English
Published: 2003
_version_ 1826259827672743936
author Waldmann, H
author_facet Waldmann, H
author_sort Waldmann, H
collection OXFORD
description New knowledge on how lymphocytes become tolerant to antigens is now enabling novel tolerance-harnessing strategies to enter the clinical arena. In the field of transplantation, monoclonal antibodies used either to deplete lymphocytes or to block T-cell function can induce tolerance in mice and non-human primates. Understanding the mechanisms underlying tolerance should enable application to the clinic. Harnessing of tolerance mechanisms may enable more judicious use of conventional immunosuppressive agents even to the point of maintenance monotherapy, so limiting drug side effects and ensuring compliance.
first_indexed 2024-03-06T18:55:57Z
format Journal article
id oxford-uuid:11d8e59d-b3b3-4a78-be7c-e076068abd92
institution University of Oxford
language English
last_indexed 2024-03-06T18:55:57Z
publishDate 2003
record_format dspace
spelling oxford-uuid:11d8e59d-b3b3-4a78-be7c-e076068abd922022-03-26T10:04:30ZThe new immunosuppression.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:11d8e59d-b3b3-4a78-be7c-e076068abd92EnglishSymplectic Elements at Oxford2003Waldmann, HNew knowledge on how lymphocytes become tolerant to antigens is now enabling novel tolerance-harnessing strategies to enter the clinical arena. In the field of transplantation, monoclonal antibodies used either to deplete lymphocytes or to block T-cell function can induce tolerance in mice and non-human primates. Understanding the mechanisms underlying tolerance should enable application to the clinic. Harnessing of tolerance mechanisms may enable more judicious use of conventional immunosuppressive agents even to the point of maintenance monotherapy, so limiting drug side effects and ensuring compliance.
spellingShingle Waldmann, H
The new immunosuppression.
title The new immunosuppression.
title_full The new immunosuppression.
title_fullStr The new immunosuppression.
title_full_unstemmed The new immunosuppression.
title_short The new immunosuppression.
title_sort new immunosuppression
work_keys_str_mv AT waldmannh thenewimmunosuppression
AT waldmannh newimmunosuppression